OSLO, Norway--(BUSINESS WIRE)--Oslo Cancer Cluster today announced that it had been awarded National Center of Excellence (NCE) status and special additional funding by the Norwegian government. This major private-public initiative in one of Europe’s rising biopharma regions aims to become the most innovative research-based industrial center in Europe for cancer diagnostics and treatment by 2015.
